GenSci to attend 58th API China

GenSci will be attending the 58th API China, China International Pharmaceutical Ingredients Fair, at the Nanjing International Exhibition Centre, Nanjing, China, on May 15 –May 17, 2007. GenSci's management executives and staff from International Commercial Development & Regulatory Affairs will be available on-site to answer questions about:

-GenSci and GenSci's products
-Partnering and business opportunities
-Further development of our business

We cordially invite all of our respected clients and professionals from all over the world who are interested in collaborating with us to visit GenSci at booth #C053.

API China is organized by the world's renowned event organizer, Reed Exhibitions, and China's most established pharmaceutical exhibition organizer, Sinopharm. API China, which focuses on bulk pharmaceuticals, fine chemicals & intermediates, excipients and drug formulation, pharmaceutical packaging material and machinery and food & cosmetic additives, attracts over 1,100 manufacturers, and 32,000 professional visitors every year. For more information about API China, please visit www.apichina.com.cn

GenSci (www.gensci-china.com) is the leading Chinese biopharmaceutical company that develops, manufactures and markets biological therapeutics focused on endocrinology and related areas, aiming at providing affordable and innovative biopharmaceutical products to patients. The company is privately-held and headquartered in Changchun, China. Products include: Jintropin™ somatropin (rhGH for injection), Jintropin™ AQ somatropin liquid pen, Scimax™ filgrastim (rhG-CSF injection), Granmac™ molgramostim (rhGM-CSF for injection), Jintrotide™ (octreotide acetate for injection) and Jintrirelin™ (triptorelin acetate injection). For more information, visit www.gensci-china.com.